Estradiol pivalate/progesterone
Estradiol pivalate/progesterone, sold under the brand name Estrotate with Progesterone, is a combination medication of estradiol pivalate, an estrogen, and progesterone, a progestogen, which was used in menopausal hormone therapy and the treatment of gynecological disorders but is no longer available. It contained 1 mg/mL ETMA and 10 mg/mL P4 in oil solution provided in vials and was administered by intramuscular injection at regular intervals.
ETMA/P4 was introduced for medical use by 1949. It was one of the first combined estrogen and progestogen medications to be marketed, and was followed by the more well-known estradiol benzoate/progesterone in 1950. Other similar estrogen–progestogen preparations were also subsequently introduced.